BioLife : to Present at September Investment Conferences
September 11, 2017 at 07:29 pm EDT
Share
11Sep
BioLife Solutions Inc. (NASDAQ: BLFS) announces that Mike Rice, President and CEO, will be presenting at two investment conferences in September:
Rodman & Renshaw 19 Annual Global Investment Conference on Tuesday, September 12th, at 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference is being held at the New York Palace Hotel in New York City. More information can be found at the event website.
Janney Montgomery Scott Bioproduction & Biostorage Forum on Tuesday, September 19, at the Union League Club in New York City
BioLife Solutions Inc. published this content on 11 September 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 11 September 2017 23:28:04 UTC.
Original documenthttp://www.biolifesolutions.com/uncategorized/biolife-solutions-present-september-investment-conferences/
Public permalinkhttp://www.publicnow.com/view/E45C3CB608A2E87C2EA610B5A063C63CF0992A4F
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Its expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution. Its biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death which result when cells and tissues are subjected to reduced temperatures. Its bioproduction tools portfolio includes human platelet lysates for cell expansion. It is a provider of biological and pharmaceutical storage and cold chain logistics. Its monitoring systems allow customers real time tracking of the storage temperatures of their materials throughout the logistics process. It operates about five storage facilities in the United States and one facility in the Netherlands.